These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

220 related items for PubMed ID: 21831900

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Longitudinal prospective study of matrix metalloproteinase-9 as a serum marker in gliomas.
    Iwamoto FM, Hottinger AF, Karimi S, Riedel E, Dantis J, Jahdi M, Panageas KS, Lassman AB, Abrey LE, Fleisher M, Deangelis LM, Holland EC, Hormigo A.
    J Neurooncol; 2011 Dec; 105(3):607-12. PubMed ID: 21710351
    [Abstract] [Full Text] [Related]

  • 3. YKL-40 and matrix metalloproteinase-9 as potential serum biomarkers for patients with high-grade gliomas.
    Hormigo A, Gu B, Karimi S, Riedel E, Panageas KS, Edgar MA, Tanwar MK, Rao JS, Fleisher M, DeAngelis LM, Holland EC.
    Clin Cancer Res; 2006 Oct 01; 12(19):5698-704. PubMed ID: 17020973
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. YKL-40 and MMP-9 as serum markers for patients with primary central nervous system lymphoma.
    Hottinger AF, Iwamoto FM, Karimi S, Riedel E, Dantis J, Park J, Panageas KS, Lassman AB, Abrey LE, Fleisher M, Holland EC, DeAngelis LM, Hormigo A.
    Ann Neurol; 2011 Jul 01; 70(1):163-9. PubMed ID: 21391238
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Elevated serum YKL-40 level predicts poor prognosis in hepatocellular carcinoma after surgery.
    Zhu CB, Chen LL, Tian JJ, Su L, Wang C, Gai ZT, Du WJ, Ma GL.
    Ann Surg Oncol; 2012 Mar 01; 19(3):817-25. PubMed ID: 21861215
    [Abstract] [Full Text] [Related]

  • 9. Prognostic significance of histological grading, p53 status, YKL-40 expression, and IDH1 mutations in pediatric high-grade gliomas.
    Antonelli M, Buttarelli FR, Arcella A, Nobusawa S, Donofrio V, Oghaki H, Giangaspero F.
    J Neurooncol; 2010 Sep 01; 99(2):209-15. PubMed ID: 20174854
    [Abstract] [Full Text] [Related]

  • 10. YKL-40 is a differential diagnostic marker for histologic subtypes of high-grade gliomas.
    Nutt CL, Betensky RA, Brower MA, Batchelor TT, Louis DN, Stemmer-Rachamimov AO.
    Clin Cancer Res; 2005 Mar 15; 11(6):2258-64. PubMed ID: 15788675
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Gene expression microarray analysis reveals YKL-40 to be a potential serum marker for malignant character in human glioma.
    Tanwar MK, Gilbert MR, Holland EC.
    Cancer Res; 2002 Aug 01; 62(15):4364-8. PubMed ID: 12154041
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Serum YKL-40 level is associated with the chemotherapy response and prognosis of patients with small cell lung cancer.
    Xu CH, Yu LK, Hao KK.
    PLoS One; 2014 Aug 01; 9(5):e96384. PubMed ID: 24801872
    [Abstract] [Full Text] [Related]

  • 15. A panel of four cytokines predicts the prognosis of patients with malignant gliomas.
    Lin Y, Zhang G, Zhang J, Gao G, Li M, Chen Y, Wang J, Li G, Song SW, Qiu X, Wang Y, Jiang T.
    J Neurooncol; 2013 Sep 01; 114(2):199-208. PubMed ID: 23748572
    [Abstract] [Full Text] [Related]

  • 16. Serum YKL-40 levels as a prognostic factor in patients with intracerebral hemorrhage.
    Jiang YX, Zhang GH, Wang ZM, Yang H.
    Clin Biochem; 2014 Dec 01; 47(18):302-6. PubMed ID: 25262987
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Extent of tumor removal and molecular markers in cerebral glioblastoma: a combined prognostic factors study in a surgical series of 105 patients.
    Salvati M, Pichierri A, Piccirilli M, Floriana Brunetto GM, D'Elia A, Artizzu S, Santoro F, Arcella A, Giangaspero F, Frati A, Simione L, Santoro A.
    J Neurosurg; 2012 Aug 01; 117(2):204-11. PubMed ID: 22655594
    [Abstract] [Full Text] [Related]

  • 19. YKL-40 is directly produced by tumor cells and is inversely linked to EGFR in glioblastomas.
    Horbinski C, Wang G, Wiley CA.
    Int J Clin Exp Pathol; 2010 Jan 01; 3(3):226-37. PubMed ID: 20224722
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.